Change in Bank Control Notices; Acquisitions of Shares of a Bank or Bank Holding Company, 72238 [2021-27604]
Download as PDF
<![CDATA[
72238
Federal Register / Vol. 86, No. 242 / Tuesday, December 21, 2021 / Notices
Dated at Washington, DC, on December 15,
2021.
James P. Sheesley,
Assistant Executive Secretary.
[FR Doc. 2021–27525 Filed 12–20–21; 8:45 am]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
FEDERAL RESERVE SYSTEM
Change in Bank Control Notices;
Acquisitions of Shares of a Bank or
Bank Holding Company
jspears on DSK121TN23PROD with NOTICES1
A. Federal Reserve Bank of Dallas
(Karen Smith, Director, Applications)
2200 North Pearl Street, Dallas, Texas
75201–2272:
1. Brittany Broke Lane, Jonestown,
Texas; by retaining voting shares of
Shelby Bancshares, Inc., and thereby
indirectly retaining voting shares of
Shelby Savings Bank, SSB, both of
Center, Texas.
Board of Governors of the Federal Reserve
System, December 16, 2021.
Michele Taylor Fennell,
Deputy Associate Secretary of the Board.
[FR Doc. 2021–27604 Filed 12–20–21; 8:45 am]
BILLING CODE P
Jkt 256001
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The notificants listed below have
applied under the Change in Bank
Control Act (Act) (12 U.S.C. 1817(j)) and
§ 225.41 of the Board’s Regulation Y (12
CFR 225.41) to acquire shares of a bank
or bank holding company. The factors
that are considered in acting on the
applications are set forth in paragraph 7
of the Act (12 U.S.C. 1817(j)(7)).
The public portions of the
applications listed below, as well as
other related filings required by the
Board, if any, are available for
immediate inspection at the Federal
Reserve Bank(s) indicated below and at
the offices of the Board of Governors.
This information may also be obtained
on an expedited basis, upon request, by
contacting the appropriate Federal
Reserve Bank and from the Board’s
Freedom of Information Office at
https://www.federalreserve.gov/foia/
request.htm. Interested persons may
express their views in writing on the
standards enumerated in paragraph 7 of
the Act.
Comments regarding each of these
applications must be received at the
Reserve Bank indicated or the offices of
the Board of Governors, Ann E.
Misback, Secretary of the Board, 20th
Street and Constitution Avenue NW,
Washington DC 20551–0001, not later
than January 5, 2022.
18:02 Dec 20, 2021
Centers for Disease Control and
Prevention
[60Day-22–22BG; Docket No. CDC–2021–
0131]
BILLING CODE 6714–01–P
VerDate Sep<11>2014
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comments on a
proposed information collection project
titled Characteristics of Patients with
Environmentally-derived Triazoleresistant Aspergillus fumigatus. This
case report form collects information on
demographics, underlying conditions,
treatments, and outcomes of patients
with triazole-resistant A. fumigatus to
inform clinical and public health
practice.
SUMMARY:
CDC must receive written
comments on or before February 22,
2022.
DATES:
You may submit comments,
identified by Docket No. CDC–2021–
0131 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8 Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
ADDRESSES:
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
Prevention, 1600 Clifton Road, NE, MS
H21–8, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
Characteristics of Patients with
Environmentally-derived Triazoleresistant Aspergillus fumigatus—New—
National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The environmental mold Aspergillus
fumigatus (A. fumigatus) is the primary
cause of invasive aspergillosis and is
associated with ∼50% mortality in highrisk patients, including stem cell and
organ transplant recipients. The use of
triazole antifungals has greatly
improved survival. However, triazoleresistant A. fumigatus infections are
E:\FR\FM\21DEN1.SGM
21DEN1
]]>Agencies
[Federal Register Volume 86, Number 242 (Tuesday, December 21, 2021)]
[Notices]
[Page 72238]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-27604]
=======================================================================
-----------------------------------------------------------------------
FEDERAL RESERVE SYSTEM
Change in Bank Control Notices; Acquisitions of Shares of a Bank
or Bank Holding Company
The notificants listed below have applied under the Change in Bank
Control Act (Act) (12 U.S.C. 1817(j)) and Sec. 225.41 of the Board's
Regulation Y (12 CFR 225.41) to acquire shares of a bank or bank
holding company. The factors that are considered in acting on the
applications are set forth in paragraph 7 of the Act (12 U.S.C.
1817(j)(7)).
The public portions of the applications listed below, as well as
other related filings required by the Board, if any, are available for
immediate inspection at the Federal Reserve Bank(s) indicated below and
at the offices of the Board of Governors. This information may also be
obtained on an expedited basis, upon request, by contacting the
appropriate Federal Reserve Bank and from the Board's Freedom of
Information Office at https://www.federalreserve.gov/foia/request.htm.
Interested persons may express their views in writing on the standards
enumerated in paragraph 7 of the Act.
Comments regarding each of these applications must be received at
the Reserve Bank indicated or the offices of the Board of Governors,
Ann E. Misback, Secretary of the Board, 20th Street and Constitution
Avenue NW, Washington DC 20551-0001, not later than January 5, 2022.
A. Federal Reserve Bank of Dallas
(Karen Smith, Director, Applications) 2200 North Pearl Street,
Dallas, Texas 75201-2272:
1. Brittany Broke Lane, Jonestown, Texas; by retaining voting
shares of Shelby Bancshares, Inc., and thereby indirectly retaining
voting shares of Shelby Savings Bank, SSB, both of Center, Texas.
Board of Governors of the Federal Reserve System, December 16,
2021.
Michele Taylor Fennell,
Deputy Associate Secretary of the Board.
[FR Doc. 2021-27604 Filed 12-20-21; 8:45 am]
BILLING CODE P
